Evidence map›Paper›PMID 41464524›Full record

ArticleJournal of clinical medicine2025

The Efficacy of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Ewing Sarcoma Patients.

Ömer Faruk Kuzu, Nuri Karadurmuş, Nebi Batuhan Kanat, Çağlar Köseoğlu, Ayşegül Dumludağ, Alper Topal, Ramazan Acar, Birol Yıldız, Musa Barış Aykan, İsmail Ertürk

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ömer Faruk KuzuOncology, Cankiri State Hospital, Çankırı 18100, Turkey.ORCID 0000-0003-3197-7861
Nuri KaradurmuşDivision of Medical Oncology, Department of Internal Medicine, Gulhane Research & Training Hospital, Ankara 06010, Turkey.ORCID 0000-0003-3291-8062
Nebi Batuhan KanatDivision of Medical Internal Medicine, Department of Internal Medicine, Gulhane Research & Training Hospital, Ankara 06010, Turkey.ORCID 0009-0006-7616-7255
Çağlar KöseoğluOncology, Gaziantep City Hospital, Gaziantep 27470, Turkey.ORCID 0000-0001-6870-1004
Ayşegül DumludağOncology, Erzurum Regional Education and Research Hospital, Erzurum 25240, Turkey.ORCID 0000-0002-1171-7782
Alper TopalOncology, Tokat Gaziosmanpasa University, Tokat 60030, Turkey.ORCID 0000-0002-9679-9245
Ramazan AcarOncology, Ufuk University Dr Rıdvan Ege Hospital, Ankara 06510, Turkey.ORCID 0000-0002-3094-899X
Birol YıldızOncology, Ufuk University Dr Rıdvan Ege Hospital, Ankara 06510, Turkey.ORCID 0000-0001-8920-6467
Musa Barış AykanDivision of Medical Oncology, Department of Internal Medicine, Gulhane Research & Training Hospital, Ankara 06010, Turkey.ORCID 0000-0001-7538-9119
İsmail ErtürkDivision of Medical Oncology, Department of Internal Medicine, Gulhane Research & Training Hospital, Ankara 06010, Turkey.ORCID 0000-0001-6835-0988

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autologous stem cell transplantationEwing sarcomahigh-dose chemotherapyprognostic factors

Identifiers

PMID41464524
PMCPMC12734121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.